Patients with cyclic vomiting syndrome suffer from recurring episodes of severe nausea and vomiting. This paper presents 6 patients who responded to I-carnitine administration. Average time between episodes was 1.7 months before carnitine administration and increased to 1.1 years after carnitine administration. Average dose of carnitine administered was 50 mg/kg. Oral carnitine may be useful to control the symptoms in patients with cyclic vomiting syndrome.
Get full access to this article
View all access options for this article.
References
1.
1. Fleisher DR, Matar M. The cyclic vomiting syndrome: a report of 71 cases and literature review. J Pediatr Gastroenterol Nutr1993;17:361-369.
2.
2. Abu-Arafeh I, Russell G. Cyclical vomiting syndrome in children: a population-based study. J Pediatr Gastroenterol Nutr1995;21:454-458.
3.
3. Abu-Arafeh IA, Russell G. Current controversies-abdominal migraine. Cephalalgia. 1993;13:138-139.
4.
4. Mortimer MJ, Kay J, Jaron A. Clinical epidemiology of childhood abdominal migraine in an urban general practice. Dev Med Child Neurol. 1993;35:243-248.
5.
5. Withers GD, Silburn SR, Forbes DA. Precipitants and aetiology of cyclic vomiting syndrome. Acta Paediatr. 1998;87:272-277.
6.
6. Li BUK, Murray RD, Heitlinger LA, et al. Is cyclic vomiting syndrome related to migraine?J Pediatr1999;134:567-572.
7.
7. Rashed H, Abell TL, Familoni BO, Cardoso S. Autonomic function in cyclic vomiting syndrome and classic migraine. Digestive Dis Sci. 1999;44 (Suppl 8):74S-78S.
8.
8. Li BUK, Fleisher DR. Cyclic vomiting syndrome: features to be explained by a pathophysiologic model. Digestive Dis Sci. 1999;44 (Suppl 8):13S-18S.
9.
9. Andersen JM, Sugerman KS, Lockhart JR, Weinberg WA. Effective prophylactic therapy for cyclic vomiting syndrome in children using amitriptyline or cyproheptadine. Pediatrics. 1977;100:977-981.
10.
10. Forbes D, Withers G. Prophylactic therapy in cyclic vomiting syndrome. J Pediatr Gastroenterol Nutr1995;21: S57-S59.
11.
11. Vanderhoof JA, Young R, Kaufman SS, Ernst L. Treatment of cyclic vomiting in childhood with erythromycin. J Pediatr Gastroenterol Nutr. 1995;21: S60-S62.
12.
12. Boles RG, Chun N, Senadheera D, Wong LJC. Cyclic vomiting syndrome and mitochondrial DNA mutations. Lancet. 1997;350:1299-1300.
13.
13. Boles RG, Williams JC. Mitochondrial disease and cyclic vomiting syndrome. Digestive Dis Sci. 1999;44:103S-107S.
14.
14. Rinaldo P. Mitochondrial fatty acid oxidation disorders and cyclic vomiting syndrome. Digestive Dis Sci. 1999;44:97S-102S.
15.
15. Wolff JA, LePhuc T, Haas R, et al. Carnitine reduces fasting ketogenesis in patients with disorders of propionate metabolism. Lancet. 1986;1:289-291.
16.
16. Roe CR, Coates PM. Mitochondrial fatty acid oxidation disorders. In: Scriver CR, Beaudet AL, Sly WS, Valle D, eds. The Metabolic and Molecular Bases of Inherited Disease, ed 7. New York: McGraw Hill; 1995:1521-1521.
